Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01264913 · ClinicalTrials.gov registry record
Cardiometabolic Risk of Shiftwork
A clinical trial, sponsored by University of Chicago.
- Terminated
- Registry status
- 64
- Enrollment target
NCT01264913: Clinical Trial study, sponsored by University of Chicago.
NCT01264913 is a clinical trial that was terminated before completion, run by University of Chicago. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01264913 was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The overall goal of the present application is to test the hypothesis that shift workers, who are chronically exposed to circadian misalignment and sleep loss, have a higher cardio-metabolic risk than day workers, and that the accumulated sleep debt and the degree of circadian misalignment both predict their elevated cardio-metabolic risk.
Interventions
- BEHAVIORAL sleep extension & circadian alignment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-03 |
Why NCT01264913 stopped before completion
NCT01264913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which sleep extension & circadian alignment is the first listed.
NCT01264913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01264913 about?
NCT01264913 is a clinical study titled "Cardiometabolic Risk of Shiftwork". The overall goal of the present application is to test the hypothesis that shift workers, who are chronically exposed to circadian misalignment and sleep loss, have a higher cardio-metabolic risk than day workers, and that the accumulated sleep debt and the degree of circadian misalignment both pred...
What is the current status of trial NCT01264913?
This trial is currently terminated. The enrollment target is 64 participants. The study started on 2009-08. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01264913?
The interventions under investigation include: sleep extension & circadian alignment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01264913?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia